Atlas Trials

The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy

Clinical trial NCT02910297 · WITHDRAWN

Trial details

NCT number
NCT02910297
Sponsor
Gillette Children's Specialty Healthcare
Status
WITHDRAWN
Study type
OBSERVATIONAL
Dravet SyndromeLennox Gastaut Syndrome
Start date
2016-09-01
Primary completion
2017-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.